SCHEMBL14180955

SCHEMBL14180955

O=c1n(CC(O)COc2ccc(F)cc2)nc2c(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3)cnn12

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 2/20 0.48
▸ CACNA1G O43497 4/20 0.44
▸ KCNH2 Q12809 2/20 0.44
▸ RAB9A P51151 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ TSHR P16473 2/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ HCAR2 Q8TDS4 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14180952 0.92 CNR1 (0.47) CNR1KMT2AMEN1TSHRALDH1A1
SCHEMBL14180958 0.91 CNR1 (0.46) CNR1CACNA1GKCNH2KMT2AMEN1
SCHEMBL14180949 0.91 CNR1 (0.47) CNR1RAB9AKMT2ANPC1TSHR
SCHEMBL14180959 0.85 CNR1 (0.50) CNR1RAB9AKMT2AMEN1NPC1
SCHEMBL14180961 0.85 CNR1 (0.48) CNR1RAB9AKMT2AMEN1NPC1
SCHEMBL14180963 0.85 CNR1 (0.48) CNR1RAB9AKMT2AMEN1NPC1
SCHEMBL14180950 0.84 KMT2A (0.46) CNR1RAB9AKMT2AMEN1NPC1
SCHEMBL14180865 0.84 CNR1 (0.51) CNR1RAB9AKMT2AMEN1NPC1
SCHEMBL4805929 0.83 CNR1 (0.47) CNR1RAB9AKMT2AMEN1NPC1
SCHEMBL14180939 0.83 CNR1 (0.47) CNR1RAB9AKMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378418-B2 Azabicyclic heterocycles as cannabinoid receptor modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2008-05-27 — — US disclosed
US-7378418-B2 Azabicyclic heterocycles as cannabinoid receptor modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2008-05-27 — — US disclosed
Send feedback